Ouwehand A J, Baan C C, Roelen D L, Vaessen L M, Balk A H, Jutte N H, Bos E, Claas F H, Weimar W
Department of Thoracic Surgery, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Transplantation. 1993 Nov;56(5):1223-9. doi: 10.1097/00007890-199311000-00033.
Alloreactive T lymphocytes are the initiators and effectors of acute rejection of organ transplants, and T cells with high-affinity receptors for antigen might be especially implicated in this process. It has been shown that the cytotoxic capacity of CTL with low affinity for alloantigens can be inhibited with CD8 mAb, while high-affinity CTL are not affected. To investigate whether the presence of such high-affinity cells in human heart transplants may be predictive for acute rejection, we analyzed their frequency in cultures derived from endomyocardial biopsies in 19 patients, 9 of whom had never experienced acute rejection and 10 who had had one or more rejection episodes. IN the rejectors, already before histological signs of rejection (myocyte damage) had developed, significantly higher donor-reactive CTL frequencies were found compared with the nonrejectors (medians of 10,586 vs 1,169 reactive cells per 10(6) tested cells, P = 0.002). After CD8 inhibition, the difference between rejectors and nonrejectors was even more pronounced (P < 0.001). In patients with rejection, the number of CD8-resistant, high-affinity CTL was higher than 1000 per million cells in all cases, while in patients who had never experienced rejection this number was less than 1000. As these CTL characteristics are already present before the first histological signs of rejection have developed, this might be used as a prognostic factors.
同种异体反应性T淋巴细胞是器官移植急性排斥反应的启动者和效应器,具有高亲和力抗原受体的T细胞可能在此过程中发挥特别重要的作用。研究表明,对同种异体抗原亲和力低的细胞毒性T淋巴细胞(CTL)的细胞毒性能力可被CD8单克隆抗体抑制,而高亲和力CTL则不受影响。为了研究人类心脏移植中此类高亲和力细胞的存在是否可预测急性排斥反应,我们分析了19例患者心内膜心肌活检培养物中它们的频率,其中9例从未经历过急性排斥反应,10例有过一次或多次排斥反应。在发生排斥反应的患者中,在排斥反应的组织学迹象(心肌细胞损伤)出现之前,与未发生排斥反应的患者相比,发现供体反应性CTL频率显著更高(每10^6个测试细胞中反应性细胞的中位数分别为10586和1169,P = 0.002)。在CD8抑制后,发生排斥反应的患者与未发生排斥反应的患者之间的差异更加明显(P < 0.001)。在发生排斥反应的患者中,所有病例中每百万细胞中CD8抗性高亲和力CTL的数量均高于1000,而在从未经历过排斥反应的患者中,这一数量少于1000。由于这些CTL特征在排斥反应的首个组织学迹象出现之前就已存在,这可能用作预后因素。